KFF Examines the Hyde Amendment and its Impact in States Without Abortion Bans
KFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →
KFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision.
This policy watch explains the April 21, 2023 United States Supreme Court's ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA's approval of mifepristone, the medication abortion pill.
This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
Ahead of the 2024 general election, a new KFF brief examines abortion ballot initiatives in progress in 13 states. These 13 states could follow six other states that have voted on constitutional amendments to protect or restrict abortion since the Supreme Court’s Dobbs decision overturning Roe v. Wade in 2022.
Following recent news about former President Trump’s potential support for a national 16-week abortion ban, KFF examines the data about how often abortions later in pregnancy occur, exploring the potential reasons why, and detailing the various laws that regulate access to abortions later in pregnancy.
Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion.
In anticipation of a ruling in a case with enormous implications for access to medication abortion in the United States, a new KFF brief explains the impact of this case, and others filed in federal courts, involving the FDA’s regulation of medication abortion.
This issue brief details some of the implications of the Supreme Court's June 13, 2024, ruling in the case Alliance for Hippocratic Medicine v. FDA.
This Polling Insight explores the abortion attitudes of Republican women voters leading up to the 2024 presidential election, including support for specific policies and their perceptions of the Republican Party on this issue.
Following the launch of Kamala Harris's presidential campaign, this analysis explores Democratic and Democratic-leaning women voters' trust in her on abortion policy. It draws on data from the KFF Survey of Women Voters, conducted prior to President Biden's decision to end his reelection bid.
© 2025 KFF
